{"id":52071,"date":"2022-12-16T12:02:11","date_gmt":"2022-12-16T11:02:11","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-microarray-market-report-2022-2028-rising-use-of-microarrays-to-diagnose-infectious-diseases-fuels-growth-researchandmarkets-com\/"},"modified":"2022-12-16T12:02:11","modified_gmt":"2022-12-16T11:02:11","slug":"global-microarray-market-report-2022-2028-rising-use-of-microarrays-to-diagnose-infectious-diseases-fuels-growth-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-microarray-market-report-2022-2028-rising-use-of-microarrays-to-diagnose-infectious-diseases-fuels-growth-researchandmarkets-com\/","title":{"rendered":"Global Microarray Market Report 2022-2028: Rising Use of Microarrays to Diagnose Infectious Diseases Fuels Growth – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Global Microarray Market Research and Forecast, 2022-2028”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe global microarray market is anticipated to grow at a CAGR of around 7.8% during the forecast period. Microarrays are one of the powerful technologies for the analysis of gene expression that can be used for various experimental purposes. The developments of microarrays have enhanced the results of genetic testing. Microarrays are used in a variety of applications, including gene discovery, disease diagnosis, drug discovery, and toxicological research.\n<\/p>\n

\nThe rising incidences of cancer are the major factor contributing to the growth of the market. Moreover, increasing prevalence of various chronic diseases and the rise of usage of microarrays technology for the diagnosis of such infectious diseases are also contributing to the growth of the microarray market.\n<\/p>\n

\nOn the contrary, the lack of funding for microarray development, as well as the cost of preparing microarrays, are the major restraints for this market. Moreover, increasing applications of microarrays such as forensic analysis, genotyping, evaluating somatic mutations in cancer, measuring predisposition to diseases is creating significant opportunities for the growth of the microarray market.\n<\/p>\n

\nSegmental Outlook<\/strong>\n<\/p>\n

\nThe global microarray market is segmented based on type, and application. On the basis of type, the market is segmented into DNA microarrays, protein microarray, peptide microarray, tissue microarray, and others (cellular microarray). Further based on application, the market is segregated into diagnosis & prognosis, pharmacogenomics & theragnostic, drug discovery and others.\n<\/p>\n

\nDNA Microarray projected to hold a significant share in the global Microarray market<\/strong>\n<\/p>\n

\nAmong types, the DNA microarray segment is projected to have a significant share in the global microarray market. The factor contributing to the growth of the segment includes increasing applications of DNA microarrays approach in various sectors and its applications include proteomics, disease monitoring, gene expression, drug discovery, and others.\n<\/p>\n

\nThis approach enables the researchers to identify and investigate the non-traceable issues and are used to detect DNA or RNA. Furthermore, the advancement of technologies in DNA microarray techniques will also be contributing to the growth of the segment. Some of the emerging technologies include glass array tends, Agilent technology, and amersham’s coating technology. Other factors such as increasing government funding, rising need for initial cancer detection, and cancer diagnosis as DNA microarrays act as a catalyst and further contributing to the segmental growth.\n<\/p>\n

\nRegional Outlooks<\/strong>\n<\/p>\n

\nThe global microarray market is further segmented based on geography including North America, Europe, Asia-Pacific, and the Rest of the World. North America is projected to have a significant share in the global microarray market due to factors that include prevailing gene-related diseases such as cancer, the presence of a well-developed genetic research sector, and increasing institutional and government funding. The US is projected to have the highest market share in the region attributed to factors such as the existence of skilled scientists in the region coupled with increasing expenditure in microarray research and development.\n<\/p>\n

\nAsia-Pacific is projected to grow significantly in the global microarray market during the forecast period<\/strong>\n<\/p>\n

\nGeographically, Asia-Pacific is estimated to witness significant growth in the global Microarray market during the forecast period. The growth is attributed to an increase in funding from the government in the healthcare sector, rising awareness towards personalized and precision medicines, and increasing various genome sequencing projects in the following region. The prevalence of chronic diseases has been increased in Indonesia and increased demand for fast and accurate diagnosis can be enabled by microarrays, therefore this will further fuel the market growth in the Asia Pacific region. Some of the key players of the market in the region include Agilent Technologies Inc, F. Hoffmann-La Roche Ltd, bioMerieux S.A., Bio-Rad Laboratories Inc, among others.\n<\/p>\n

\nThe Report Covers<\/strong>\n<\/p>\n